Work

Tofacitinib (cp-690,550), an oral Janus Kinase Inhibitor: Pooled phase 3 analysis in an Australian Rheumatoid Arthritis Study Population

Year: 2012

Type: article

Source: Internal Medicine Journal

Authors: A. Taylor, Peter Nash, S M Hall, Graeme Jones, Peter Youssef, Benjamin Porter-Brown, Lucas Thompson, M. C. Genovese

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2248533790

FWCI: 1.6

Cites:

Cited by: 9

Related to: 10